Cargando...
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
BACKGROUND: Clinical trials have established the efficacy of ranibizumab for the treatment of neovascular age-related macular degeneration (AMD). In addition, bevacizumab is used off-label to treat AMD, despite the absence of similar supporting data. METHODS: In a multicenter, single-blind, noninfer...
Gardado en:
| Formato: | Artigo |
|---|---|
| Idioma: | Inglês |
| Publicado: |
2011
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3157322/ https://ncbi.nlm.nih.gov/pubmed/21526923 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1102673 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|